Glucose Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2016	FY 2015	FY 2014
Period Ending	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Net Income	-0.36	-0.34	-0.48	-0.41	-0.27	-0.67
Depreciation & Amortization	-	-	0	0	-	-
Other Amortization	-	-	-	0.24	0.15	0.1
Stock-Based Compensation	0.21	0.31	0.52	0	0.03	0.37
Provision & Write-off of Bad Debts	-	0.01	-	-	-	-
Other Operating Activities	-	-	-0.02	-	-	0.03
Change in Accounts Receivable	-0.12	-0.02	0.01	-0.01	-0	-
Change in Inventory	-0.08	-0.01	-0.11	0.01	-0.01	0.01
Change in Accounts Payable	0	-0.02	-0	0.13	-0.06	0.02
Change in Other Net Operating Assets	-	-	-	0	0.04	-
Operating Cash Flow	-0.35	-0.07	-0.07	-0.04	-0.12	-0.14
Sale (Purchase) of Intangibles	-	-	-0	-	-	-
Investment in Securities	-	-	-	0	-0	-
Investing Cash Flow	-	-	-0	0	-0	-
Short-Term Debt Issued	-	-	-	0.13	0.11	0.14
Total Debt Issued	-	-	-	0.13	0.11	0.14
Short-Term Debt Repaid	-	-0.1	-0.22	-0.07	-	-
Total Debt Repaid	-	-0.1	-0.22	-0.07	-	-
Net Debt Issued (Repaid)	-	-0.1	-0.22	0.06	0.11	0.14
Preferred Dividends Paid	-0.1	-0.1	-0.05	-	-	-
Dividends Paid	-0.1	-0.1	-0.05	-	-	-
Financing Cash Flow	-0.1	0.76	0.09	0.06	0.11	0.14
Net Cash Flow	-0.45	0.68	0.02	0.02	-0	0
Cash Interest Paid	-	0	0.01	-	-	-
Levered Free Cash Flow	-	-0.05	-	0.07	-0.02	0.06
Unlevered Free Cash Flow	-	-0.05	-	0.03	-0.1	0.03
Change in Working Capital	-0.2	-0.05	-0.1	0.13	-0.04	0.03

Updated Jan 9, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.